COLONSOFT

This brand name is authorized in Finland

Active ingredients

The drug COLONSOFT contains a combination of these active pharmaceutical ingredients (APIs):

1 Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

Read about Potassium chloride
2 Macrogol 4000
UNII 4R4HFI6D95 - POLYETHYLENE GLYCOL 4000

High molecular weight (4000) macrogols are long linear polymers which retain water molecules by means of hydrogen bonds. When administered by the oral route, they lead to an increase in volume of intestinal fluids.

Read about Macrogol
3 Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

Read about Sodium chloride
4 Sodium bicarbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE

Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide.

Read about Sodium bicarbonate
5 Sodium sulfate
UNII 0YPR65R21J - SODIUM SULFATE

Sodium Sulfate Anhydrous is the anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions.

Read about Sodium sulfate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A06AD65 Macrogol, combinations A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives
Discover more medicines within A06AD65

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FI Lรครคkealan turvallisuus- ja kehittรคmiskeskus Identifier(s): 009645, 069614

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.